Concepedia

Publication | Open Access

Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2

94

Citations

72

References

2020

Year

Abstract

The MESV developed in this study is capable of generating immune response against COVID-19. Therefore, if designed MESV further investigated experimentally, it would be an effective vaccine candidate against SARS-CoV-2 to control and prevent COVID-19.

References

YearCitations

Page 1